세계의 노안 교정 시장(2025년) : 분석(2024-2030년)

The "2025 Presbyopia Correction Market Report" offers a detailed analysis of the global market for surgical and pharmaceutical presbyopia treatments and forecasts market performance through 2030. It includes regional and global market sizing, identification of key trends, and discussion of the factors most likely to shape future growth.

This report examines procedure volumes, estimates serviceable patient populations, and forecasts the presbyopia markets for laser vision correction procedures (LASIK, lenticule extraction, and surface ablation), presbyopia-correcting IOLs (PC-IOLs), and pharmaceutical drops by region through 2030.

The report is designed for industry stakeholders-manufacturers, market analysts, ophthalmologists, optometrists, and investors-seeking a clear and actionable view of the presbyopia correction market and its potential over the next five years.

Contents:

The report includes regional forecasts for eight markets-United States, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World-along with estimates of available and serviceable patient populations. It presents five-year forecasts for procedure volumes and manufacturer revenue across key presbyopia treatment categories.

Covered treatment categories include presbyopia-correcting IOLs, laser vision correction procedures (LASIK, lenticule extraction, and surface ablation), and pharmaceutical drops. The report evaluates market dynamics, adoption trends, and competitive positioning within each of these segments.

Also included is analysis of the technologies and devices used in presbyopia correction, refractive lasers, and IOLs.

Methodology:

This report draws on a wide range of trusted sources to deliver comprehensive and objective market intelligence. Our analysis is grounded in primary data from Market Scope's proprietary global surveys, interviews, and polls of ophthalmologists, as well as detailed conversations with industry executives and key opinion leaders. We also leverage our exclusive disease and demographic models-built specifically for the ophthalmic market-to provide accurate projections and nuanced insight by subspecialty and region.

In addition to firsthand research, this report incorporates key secondary sources, including peer-reviewed medical literature, financial disclosures from public companies, and presentations shared at leading ophthalmic conferences. The result is a well-rounded and data-rich resource designed to inform strategic decisions across the presbyopia market.